Hybrid treatment of atrial fibrillation

Prabhat Kumar1, Andy C Kiser2, Anil K Gehi1

  • 1Division of Cardiology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Insights

Hybrid catheter ablation (CA) combines epicardial and endocardial approaches for atrial fibrillation (AF). This review explores its potential to improve AF treatment, especially for persistent cases.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Minimally Invasive Cardiac Surgery

Background:

  • Atrial fibrillation (AF) management relies on endocardial catheter ablation (CA) and surgical Maze procedures.
  • Endocardial CA shows limited efficacy in persistent AF, leading to high recurrence rates.
  • Hybrid CA, combining epicardial and endocardial approaches, offers enhanced lesion formation and arrhythmia circuit treatment.

Purpose of the Study:

  • To review the hybrid catheter ablation (CA) procedure for atrial fibrillation (AF).
  • To discuss the rationale, methods, tools, and efficacy of hybrid CA.
  • To identify optimal patient populations and techniques for hybrid AF ablation.

Main Methods:

  • Review of existing literature on hybrid CA for AF.
  • Discussion of techniques including epicardial and endocardial ablation strategies.
  • Analysis of available tools and reported outcomes for hybrid procedures.

Main Results:

  • Hybrid CA potentially improves success rates, particularly in persistent or long-standing persistent AF.
  • It allows for robust lesion formation and treatment of residual arrhythmia circuits.
  • The procedure may be beneficial for patients with significant structural heart disease.

Conclusions:

  • Hybrid CA presents a promising approach to enhance AF ablation efficacy.
  • Further research is needed to define ideal patient selection and optimize techniques.
  • This combined epicardial-endocardial strategy may overcome limitations of traditional CA.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
630
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
4.0K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.0K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
585
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
469
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
546